Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Vera Therapeutics, Inc. (VERA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
30 Jan 2024
Katabi Maha
Director
Vera Therapeutics, Inc.
(VERA)
3,628,446
+4%
161,290
$31.00
$4,999,990.00
SELL
10 Jan 2024
COMMODORE CAPITAL LP
10% Owner
Vera Therapeutics, Inc.
(VERA)
4,400,000
-19%
1,050,000
$18.00
$18,900,000.00
SELL
21 Aug 2023
Fordyce Marshall
President and CEO, Director, Officer
Vera Therapeutics, Inc.
(VERA)
243,361
-2%
5,210
$16.66
$86,778.81
SELL
21 Aug 2023
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
26,962
-5%
1,490
$16.66
$24,817.14
SELL
21 Aug 2023
Lin Celia
Chief Medical Officer, Officer
Vera Therapeutics, Inc.
(VERA)
11,010
-11%
1,490
$16.65
$24,815.50
BUY
23 Jun 2023
Grant Sean
Chief Financial Officer, Officer
Vera Therapeutics, Inc.
(VERA)
5,992
+504%
5,000
$16.60
$83,000.00
BUY
20 Jun 2023
COMMODORE CAPITAL LP
10% Owner
Vera Therapeutics, Inc.
(VERA)
5,450,000
+8%
448,217
$15.17
$6,799,003.50
BUY
30 Mar 2023
SEIDENBERG BETH C
Director
Vera Therapeutics, Inc.
(VERA)
1,949,295
+0%
2,300
$7.24
$16,650.85
BUY
28 Mar 2023
SEIDENBERG BETH C
Director
Vera Therapeutics, Inc.
(VERA)
1,946,995
+1%
23,908
$7.24
$173,191.94
BUY
24 Mar 2023
SEIDENBERG BETH C
Director
Vera Therapeutics, Inc.
(VERA)
1,923,087
+0%
3,466
$7.24
$25,102.11
BUY
17 Mar 2023
SEIDENBERG BETH C
Director
Vera Therapeutics, Inc.
(VERA)
1,919,621
+4%
89,297
$7.13
$636,914.50
BUY
15 Mar 2023
SEIDENBERG BETH C
Director
Vera Therapeutics, Inc.
(VERA)
1,830,324
+5%
92,941
$7.10
$660,278.25
BUY
23 Feb 2023
SEIDENBERG BETH C
Director
Vera Therapeutics, Inc.
(VERA)
1,664,902
+0%
200
$7.24
$1,447.00
BUY
13 Feb 2023
SEIDENBERG BETH C
Director
Vera Therapeutics, Inc.
(VERA)
1,664,702
+0%
10,072
$7.20
$72,490.20
BUY
9 Feb 2023
SEIDENBERG BETH C
Director
Vera Therapeutics, Inc.
(VERA)
1,654,630
+0%
400
$7.25
$2,900.00
BUY
6 Feb 2023
Grant Sean
Chief Financial Officer, Officer
Vera Therapeutics, Inc.
(VERA)
49,933
+40%
14,285
$7.00
$99,995.00
BUY
6 Feb 2023
Young Joseph R
SVP, Finance, Chief Acct Offcr, Officer
Vera Therapeutics, Inc.
(VERA)
22,679
+33%
5,714
$7.00
$39,998.00
BUY
6 Feb 2023
Sofinnova Venture Partners X, L.P.
10% Owner
Vera Therapeutics, Inc.
(VERA)
3,467,156
+8%
285,714
$7.00
$1,999,998.00
BUY
6 Feb 2023
ENRIGHT PATRICK G
Director, 10% Owner
Vera Therapeutics, Inc.
(VERA)
1,714,285
+100%
1,714,285
$7.00
$11,999,995.00
BUY
6 Feb 2023
Longitude Capital Partners IV, LLC
10% Owner
Vera Therapeutics, Inc.
(VERA)
1,714,285
+100%
1,714,285
$7.00
$11,999,995.00
BUY
6 Feb 2023
Young Joseph R
SVP, Finance, Chief Acct Offcr, Officer
Vera Therapeutics, Inc.
(VERA)
22,679
+33%
5,714
$7.00
$39,998.00
BUY
6 Feb 2023
Grant Sean
Chief Financial Officer, Officer
Vera Therapeutics, Inc.
(VERA)
49,933
+40%
14,285
$7.00
$99,995.00
BUY
3 Feb 2023
SEIDENBERG BETH C
Director
Vera Therapeutics, Inc.
(VERA)
1,654,230
+23%
311,078
$7.10
$2,209,588.20
SELL
16 Dec 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
26,821
-7%
2,212
$19.49
$43,115.93
SELL
12 Dec 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
26,821
-42%
19,711
$18.26
$359,972.94
SELL
7 Dec 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
26,821
-1%
494
$16.47
$8,136.18
SELL
17 Nov 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
27,315
-10%
3,289
$15.85
$52,127.93
SELL
9 Nov 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
27,315
-1%
494
$16.54
$8,170.76
SELL
18 Oct 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
27,809
-23%
8,590
$19.41
$166,734.94
SELL
5 Oct 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
27,809
-3%
988
$21.64
$21,380.32
SELL
20 Sep 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
28,797
-36%
16,840
$20.72
$348,944.00
SELL
13 Sep 2022
Fordyce Marshall
President and CEO, Director, Officer
Vera Therapeutics, Inc.
(VERA)
181,150
-10%
22,363
$21.16
$473,236.25
SELL
7 Sep 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
28,797
-3%
988
$18.63
$18,406.44
SELL
7 Sep 2022
Fordyce Marshall
President and CEO, Director, Officer
Vera Therapeutics, Inc.
(VERA)
181,150
-10%
21,891
$20.37
$445,878.70
SELL
19 Aug 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
29,785
-22%
8,539
$19.13
$163,389.06
SELL
12 Aug 2022
Fordyce Marshall
President and CEO, Director, Officer
Vera Therapeutics, Inc.
(VERA)
137,400
-12%
20,528
$20.16
$413,799.34
SELL
3 Aug 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
17,285
-5%
988
$16.81
$16,608.28
SELL
19 Jul 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
18,273
-38%
11,444
$16.01
$183,271.10
SELL
14 Jul 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
21,023
-30%
9,104
$15.14
$137,863.72
SELL
7 Jul 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
23,688
-28%
9,666
$15.05
$145,453.39
SELL
22 Jun 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
23,994
-6%
1,545
$15.01
$23,197.95
SELL
17 Jun 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
25,194
-18%
5,887
$15.04
$88,565.49
SELL
31 May 2022
Curley Joanne
Chief Development Officer, Officer
Vera Therapeutics, Inc.
(VERA)
25,194
-1%
400
$15.22
$6,086.20
BUY
10 Feb 2022
Longitude Capital Partners IV, LLC
10% Owner
Vera Therapeutics, Inc.
(VERA)
3,429,927
+10%
333,333
$15.00
$4,999,995.00
BUY
10 Feb 2022
Sofinnova Venture Partners X, L.P.
10% Owner
Vera Therapeutics, Inc.
(VERA)
3,181,442
+9%
266,666
$15.00
$3,999,990.00
BUY
10 Feb 2022
ENRIGHT PATRICK G
Director, 10% Owner
Vera Therapeutics, Inc.
(VERA)
3,429,927
+10%
333,333
$15.00
$4,999,995.00
BUY
15 Jun 2021
Grant Sean
Chief Financial Officer, Officer
Vera Therapeutics, Inc.
(VERA)
2,816
+228%
5,000
$13.60
$68,004.00
BUY
18 May 2021
Longitude Capital Partners IV, LLC
10% Owner
Vera Therapeutics, Inc.
(VERA)
3,096,594
+41%
909,090
$11.00
$9,999,990.00
BUY
18 May 2021
Sofinnova Venture Partners X, L.P.
10% Owner
Vera Therapeutics, Inc.
(VERA)
2,914,776
+33%
727,272
$11.00
$7,999,992.00
BUY
18 May 2021
ENRIGHT PATRICK G
Director, 10% Owner
Vera Therapeutics, Inc.
(VERA)
3,096,594
+41%
909,090
$11.00
$9,999,990.00
BUY
18 May 2021
Katabi Maha
Director, 10% Owner
Vera Therapeutics, Inc.
(VERA)
2,914,776
+33%
727,272
$11.00
$7,999,992.00
BUY
17 May 2021
EMSTER KURT VON
Director
Vera Therapeutics, Inc.
(VERA)
2,960,231
+36%
790,555
$11.02
$8,714,653.00
BUY
13 May 2021
Abingworth LLP
10% Owner
Vera Therapeutics, Inc.
(VERA)
2,960,231
+35%
772,727
$11.00
$8,499,997.00
Home